The cyclin kinase inhibitor p21(WAF1, CIP1) is increased in experimental diabetic nephropathy: Potential role in glomerular hypertrophy

Journal of the American Society of Nephrology

Volumn 9, Issue 6, 1998, Pages 986-993

  Kuan, Chia Jen ^a   Al Douahji, Mouhannad ^a   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DNA; GLUCOSE; PROTEIN; PROTEIN P27; STREPTOZOCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; MESANGIUM CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

EID: 0031801448     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. National Institutes of Health: U.S. Renal Data System, 1996
2. Osterby R, Gundersen HJG: Fast accumulation of basement membrane material and the acute rate of morphological changes in acute experimental diabetic glomerular hypertrophy. Diabetologia 18: 493-500, 1980
3. Rabkin R, Fervenza FC: Renal hypertrophy and kidney disease in diabetes. Diabetes Metab Rev 12: 217-241, 1996
4. Schwieger J, Fine LG: Renal hypertrophy, growth factors, and nephropathy in diabetes mellitus. Semin Nephrol 10: 242-253, 1990
5. Nahman NS, Leonhart KL, Cosio FG, Hebert CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 41: 396-402, 1992
6. Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in progressive crescentic glomerulonephritis. Lab Invest 74: 941-951, 1996
7. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42: 647-656, 1992
8. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995
9. Seyer-Hansen K: Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med 51: 551-555, 1976
10. Seyer-Hansen K: Renal hypertrophy in experimental diabetes mellitus. Kidney Int 23: 643-646, 1983
11. Osterby R, Gundersen HJG: Glomerular size and structure in diabetes mellitus. Diabetologia 11: 451-456, 1975
12. Rasch R, Norgaard JOR: Renal enlargement: Comparative auto-radiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 25: 280-287, 1983
13. Mauer SM: Structural-functional correlations of diabetic nephropathy. Kidney Int 45: 612-622, 1994
14. Norbury C, Nurse P: Animal cell cycles and their control. Annu Rev Biochem 61: 441-471, 1992
15. Shankland SJ: Cell cycle control and renal disease. Kidney Int 52: 294-308, 1997
16. Pardee AB: G1 events and regulation of cell proliferation. Science 246: 603-608, 1989
17. Hunt T: Cyclins and their partners: From a simple idea to complicated reality. Semin Cell Biol 2: 213-222, 1991
18. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995
19. INK4b is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261, 1994
20. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993
21. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge J: The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993
22. Luo Y, Hurwitz J, Massague J: Cell-cycle inhibition by independent CDK and PCNA binding domains in p21CIP1. Nature 375: 159-161, 1995
23. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J: Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78: 59-66, 1994
24. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994
25. KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9: 650-662, 1995
26. Lee M-H, Reynisdottir I, Masague J: Cloning of p57Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9: 639-649, 1995
27. Coats S, Flanagan WM, Nourse J, Roberts JM: Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877-880, 1996
28. Shankland SJ, Pippin J, Flanagan M, Coats SR, Nangaku M, Gordon KL, Roberts JM, Couser WG, Johnson RJ: Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Kidney Int 51: 1088-1099, 1997
29. Savill J, Mooney A, Hughes J: Apoptosis and renal scarring. Kidney Int 49: S14-S17, 1996
30. Wang J, Walsh K: Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273: 359-361, 1996
31. Shankland SJ, Scholey JW: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 46: 430-442, 1994
32. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
33. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90: 1814-1818, 1993
34. Ziyadeh FN, Sharma K: Role of transforming growth factor-β in diabetic glomerulosclerosis and renal hypertrophy. Kidney Int 48: S34-S36, 1995
35. Sharma K, Ziyadeh FN: Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 36: F1094-F1101, 1994
36. Shankland SJ, Pippin J, Flanagan M, Coats SR, Nangaku M, Fero M, Gordon KL, Roberts JM, Couser WG, Johnson RJ: Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Kidney Int 51: 1088-1099, 1997
37. Rabinovitch PS, Kubbies M, Chen YC, Schindler D, Hoehn H: BrdU-Hoechst flow cytometry: A unique tool for quantitative cell cycle analysis. Exp Cell Res 174: 309-318, 1988
38. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ: Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50: 1230-1239, 1996
39. Shankland SJ, Hamel PA, Scholey JW: Cyclin and cyclin-dependent kinase expression in the remnant glomerulus. J Am Soc Nephrol 8: 368-375, 1996
40. Bradley GM, Bensen ES: Clinical Diagnosis by Laboratory Methods, 15th Ed., edited by Davidson HJ, Philadelpha, W. B. Saunders, 1974, p 74
41. Pinto JA, Brewer DB: Glomerular morphometry. I. Combined light and electron microscope studies in normal rats. Lab Invest 30: 657, 1974
42. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94: 2105-2116, 1994
43. Shankland SJ, Floege J, Thomas SE, Nangaku M, Hugo C, Pippin J, Henne K, Hockenberry DM, Johnson RJ, Couser WG: Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 52: 404-413, 1997
44. Wolf G, Stahl RAK: Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1. Kidney Int 50: 2112-2119, 1996
45. Hengst L, Reed SI: Translational control of p27 accumulation during the cell cycle. Science 271: 1861-1864, 1996
46. Pagano M, Tam SW, Theodoras AM, Beer-Romera P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685, 1995
47. Yoshida Y, Fogo A, Ichikawa I: Glomerular hemodynamic changes vs hypertrophy in experimental glomerular sclerosis. Kidney Int 35: 654-660, 1989
48. Bilous RW, Mauer SM, Sutherland DER, Steffes MW: Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes 38: 1142-1147, 1989
49. Preisig PA, Franch HA: Renal epithelial hyperplasia and hypertrophy. Semin Nephrol 15: 327-340, 1995
50. Wolf G, Schroeder R, Ziyadeh FN, Thaiss F, Zahner G, Stahl RAK: High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: Relationship to hypertrophy. Am J Physiol 42: F348-F356, 1997
51. Franch HA, Shay JW, Alpern RJ, Preisig PA: Involvement of pRb family in TGFβ-dependent epithelial cell hypertrophy. J Cell Biol 129: 245-254, 1995
52. Liu B, Preisig PA: TGFβ-mediated conversion of EGF-induced hyperplasia to hypertrophy involves cyclin E, but not cyclin D kinase regulation, and is dependent on cells being in a confluent state [Abstract]. J Am Soc Nephrol 7: 1661, 1996
53. Terada Y, Yamada T, Nakashima O, Sasaki S, Marumo F: Angiotensin II-induced p21CIP1 via JAK2-STAT1 pathway and caused hypertrophy in proximal tubule cells [Abstract]. J Am Soc Nephrol 7: 1776, 1996
54. Shankland SJ, Hamel PA, Scholey JW: Cyclin and cyclin-dependent kinase expression in the glomeruli of normal, diabetic and renal-ablated rats [Abstract]. J Am Soc Nephrol 5: 701, 1994
55. Shankland SJ, Hamel PA, Scholey JW: Phosphorylation of retinoblastoma protein in glomeruli of normal, diabetic and renal-ablated rats. J Am Soc Nephrol 5: 701, 1994
56. Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB: TGF-β1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-CDK2 activation and retinoblastoma protein phosphorylation. Kidney Int 51: 1228-1236, 1996
57. Terada Y, Yamada T, Sasaki S, Marumo F: Overexpression of cyclin D1 and cell cycle inhibitors (p16INK4 and p21cip1) using adenovirus vectors regulates proliferation in rat mesangial cells [Abstract]. J Am Soc Nephrol 6: 778, 1995
58. Meikrantz W, Schegal R: Apoptosis and the cell cycle. J Cell Biochem 58: 160-174, 1995
59. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int 49: 103-111, 1996
60. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47: 114-121, 1995
61. Ortiz A, Ziyadeh FN, Neilson EG: Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Invest Med 45: 50-56, 1997